Related Experiment Video
Updated: Jun 29, 2025

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
Evaluating the impact of lactase supplementation on infant colic: Study protocol for a systematic review of
Anna Kozłowska-Jalowska1, Agata Stróżyk1, Andrea Horvath1
1Department of Pediatrics The Medical University of Warsaw Warsaw Poland.
Insights
Lactase supplementation may help manage infant colic, a common condition in newborns. This systematic review examines the effectiveness and safety of using lactase for infant colic relief.
Area of Science:
- Pediatrics
- Gastroenterology
- Evidence-based Medicine
Background:
- Infant colic is a prevalent functional gastrointestinal disorder in early infancy.
- The exact causes of infant colic are not fully understood, but lactase deficiency is a potential contributing factor.
- Current evidence on dietary interventions and lactase supplementation for infant colic is limited.
Purpose of the Study:
- To systematically review the efficacy and safety of oral lactase supplementation for managing infant colic.
- To synthesize findings from randomized controlled trials (RCTs) on lactase for infant colic.
Main Methods:
- Systematic review of RCTs comparing oral lactase supplementation with placebo or no intervention.
- Searches conducted in Cochrane CENTRAL, MEDLINE, and EMBASE for infants under 6 months with colic.
- Risk of bias assessed using the Cochrane Collaboration's risk-of-bias tool (Version 2).
Main Results:
- Primary outcome: number of responders (defined as reduced daily crying).
- Secondary outcomes: crying duration/frequency, infant sleep, parental satisfaction, infant discomfort, hospital admissions, quality of life, and adverse events.
- Data synthesis will focus on comparing lactase supplementation to control groups.
Conclusions:
- The review will provide evidence on the effectiveness and safety of lactase supplementation for infant colic.
- Findings will inform clinical practice and future research directions in managing infant colic.
- Results will be disseminated through peer-reviewed publications and conference presentations.
Abstract:
Infant colic is a common functional gastrointestinal disorder that affects infants during their first months of life. The etiology of this condition remains unclear. However, some studies suggest lactase deficiency may be a contributing factor. Currently, the evidence on dietary treatment and lactase supplementation for management of infant colic is limited. We aim to systematically review evidence on the efficacy and safety of using a lactase supplementation for managing infant colic. The Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Library), MEDLINE, and EMBASE will be searched to identify randomized controlled trials comparing oral lactase supplementation with placebo or no intervention in infants aged less than 6-month-old with infant colic using any recognized definition. The risk of bias will be assessed using the second version of the Cochrane Collaboration's risk-of-bias tool. The main outcome will be the number of responders in each group after treatment, defined as infants who experienced a decrease in daily crying as reported by the study authors. Additional outcomes will include the duration and frequency of crying episodes, infant sleep duration, parental satisfaction, discomfort of infants, number of hospital admissions, family quality of life, and adverse events during the intervention. The study findings will be published in a peer-reviewed journal and will be submitted to relevant conferences.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

